Aya Ozaki

723 total citations
26 papers, 495 citations indexed

About

Aya Ozaki is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Family Practice. According to data from OpenAlex, Aya Ozaki has authored 26 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 6 papers in Family Practice. Recurrent topics in Aya Ozaki's work include Medication Adherence and Compliance (6 papers), Heart Failure Treatment and Management (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Aya Ozaki is often cited by papers focused on Medication Adherence and Compliance (6 papers), Heart Failure Treatment and Management (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Aya Ozaki collaborates with scholars based in United States, Japan and Canada. Aya Ozaki's co-authors include Ryoichi Katsumata, Akira Furuya, Tatsuzo Oka, Cynthia A. Jackevicius, Dennis T. Ko, Quan Le, Janet K. Han, Toru Beppu, T Uozumi and Kazuhiko Arima and has published in prestigious journals such as Circulation, Journal of Bacteriology and Journal of Clinical Microbiology.

In The Last Decade

Aya Ozaki

23 papers receiving 468 citations

Peers

Aya Ozaki

CCM

GENET

EPIDE

Oyere K. Onuma United States

Jonathan Edwards United States

Yukihisa Miyazawa Japan

Rita Carolina Figueiredo Duarte Brazil

Surender Singh India

Szu-Han Chen Taiwan

Mongi Benjeddou South Africa

Yong Hoon Lee South Korea

Michael Parks United Kingdom

S. L. Nightingale United States

Oyere K. Onuma United States

Aya Ozaki

88 ×0.5

CCM

119 ×0.7

20 ×0.2

GENET

37 ×0.8

29 ×0.6

EPIDE

Citations per year, relative to Aya Ozaki Aya Ozaki (= 1×) peers Oyere K. Onuma

Countries citing papers authored by Aya Ozaki

Since Specialization

Citations

This map shows the geographic impact of Aya Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Ozaki more than expected).

Fields of papers citing papers by Aya Ozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Ozaki. The network helps show where Aya Ozaki may publish in the future.

Co-authorship network of co-authors of Aya Ozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Ozaki. A scholar is included among the top collaborators of Aya Ozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Ozaki. Aya Ozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsumoto, Jun, Naohiro Iwata, Takahiro Niimura, et al.. (2024). Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study. International Journal of Clinical Pharmacy. 46(3). 745–750. 4 indexed citations

Matsumoto, Jun, Naohiro Iwata, Aya Ozaki, et al.. (2024). A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases. International Journal of Clinical Pharmacy. 46(2). 536–541. 4 indexed citations

Rodríguez-Fuster, Alberto, Aya Ozaki, Douglas S. Lee, et al.. (2024). Abstract 4136009: Adherence and Persistence to Guideline-Directed Medical Therapy in Patients with Heart Failure: A Systematic Review and Meta-Analysis. Circulation. 150(Suppl_1).

Ozaki, Aya, et al.. (2024). Severe Delayed-Onset Meningitis Developed One Year After a Basilar Skull Fracture Without a Cerebrospinal Fluid Leak: A Case Report. Cureus. 16(12). e75261–e75261.

Sayer, M., et al.. (2024). Sex-based disparities with cost-related medication adherence issues in patients with hypertension, ischemic heart disease, and heart failure. Journal of the American Medical Informatics Association. 31(12). 2924–2931. 5 indexed citations

Hamano, Hirofumi, Takahiro Niimura, Aya Ozaki, et al.. (2023). Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics. International Journal of Cancer. 153(8). 1472–1476. 8 indexed citations

Ozaki, Aya, Dennis T. Ko, Alice Chong, et al.. (2023). Prescribing patterns and factors associated with sodium–glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease. CMAJ Open. 11(3). E494–E503. 24 indexed citations

Ozaki, Aya, Alice Chong, Maneesh Sud, et al.. (2023). Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes. Pharmacoepidemiology and Drug Safety. 33(1). e5704–e5704. 1 indexed citations

Ozaki, Aya, Cynthia A. Jackevicius, Alice Chong, et al.. (2022). Hospital‐Level Variation in Ticagrelor Use in Patients With Acute Coronary Syndrome. Journal of the American Heart Association. 11(13). e024835–e024835. 4 indexed citations

10.

Ozaki, Aya, et al.. (2022). Health Disparities in Pharmacy Practice Within the Community: Let's Brainstorm for Solutions. Frontiers in Public Health. 10. 847696–847696. 15 indexed citations

11.

Ozaki, Aya, et al.. (2021). Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction. Circulation Cardiovascular Quality and Outcomes. 14(9). e007665–e007665. 8 indexed citations

12.

Ozaki, Aya, Harlan M. Krumholz, Freny Vaghaiwalla Mody, & Cynthia A. Jackevicius. (2021). National Trends in the Use of Sacubitril/Valsartan. Journal of Cardiac Failure. 27(8). 839–847. 14 indexed citations

13.

Hamaguchi, Shogo, et al.. (2021). Contribution of ATP-Mediated Positive Feedback to Sympathetic Nerve-Induced Positive Inotropy in Guinea Pig Ventricular Myocardium. Biological and Pharmaceutical Bulletin. 44(3). 458–460. 3 indexed citations

14.

Ozaki, Aya, et al.. (2020). Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation. Circulation Cardiovascular Quality and Outcomes. 13(3). e005969–e005969. 153 indexed citations

15.

Ozaki, Aya, et al.. (2019). Antimicrobial Stewardship Opportunities in Patients with Bacteremia Not Identified by BioFire FilmArray. Journal of Clinical Microbiology. 57(5). 9 indexed citations

16.

Ozaki, Aya, et al.. (2017). Cross-cultural Comparison of Pharmacy Students’ Attitudes, Knowledge, Practice, and Barriers Regarding Evidence-based Medicine. American Journal of Pharmaceutical Education. 83(5). 6710–6710. 10 indexed citations

17.

Sakakibara, Hiroyuki, Aya Ozaki, Atsumi Suzuki, et al.. (2009). Effects of St John's Wort extracts on corticosterone levels dysregulated by social isolation stress. 26(2). 86–92. 1 indexed citations

18.

Katsumata, Ryoichi, Aya Ozaki, Tatsuzo Oka, & Akira Furuya. (1984). Protoplast transformation of glutamate-producing bacteria with plasmid DNA. Journal of Bacteriology. 159(1). 306–311. 136 indexed citations

19.

Satoh, Kazuo, Takehiko Yasumizu, Yasuo Kawai, et al.. (1981). In vitro production of prostaglandins E, F, and 6-KETO prostaglandin F1α by human pregnant uterus, decidua and amnion. Prostaglandins and Medicine. 6(4). 359–368. 35 indexed citations

20.

Uozumi, T, Aya Ozaki, Toru Beppu, & Kazuhiko Arima. (1980). New cryptic plasmid of Bacillus subtilis and restriction analysis of other plasmids found by general screening. Journal of Bacteriology. 142(1). 315–318. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact